Trial Profile
An Open Label Phase 1 Study in Healthy Adult Male Subjects to Determine the Mass Balance Recovery, Absorption, Metabolism, and Excretion of [14C] Vebicorvir Following Single Oral Dose Administration
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Aug 2022
Price :
$35
*
At a glance
- Drugs Vebicorvir (Primary)
- Indications Hepatitis B
- Focus Pharmacokinetics
- Sponsors Assembly Biosciences
- 26 Jun 2022 Results reporting disposition and mass balance recovery of Vebicorvir inhealthy human subjects using clinical data from this trial presented at The International Liver Congress 2022
- 08 Jan 2021 Status changed from recruiting to completed.
- 10 Apr 2018 New trial record